(Reuters Health) – The proportion of boys and young men in the U.S. receiving the human papillomavirus (HPV) vaccine has more than tripled since 2011, new research shows.
https://www.teleconsulteurope.com/wp-content/uploads/2014/11/teleconsult-logo-300x124.png00Reuters: Health Newshttps://www.teleconsulteurope.com/wp-content/uploads/2014/11/teleconsult-logo-300x124.pngReuters: Health News2018-03-30 20:18:112018-03-30 20:18:11HPV vaccine coverage on the rise, but still far from 2020 goal